{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "CYXONE AB  SK-,75", "longName": "Cyxone AB (publ)", "messageBoardId": "finmb_330187969", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 16.587677, "regularMarketPrice": 0.0492, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.51953125, "fiftyTwoWeekLow": 0.0247, "fiftyTwoWeekHigh": 0.1024, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.03, "sharesOutstanding": 98444704, "bookValue": 0.222, "fiftyDayAverage": 0.041184, "fiftyDayAverageChange": 0.008015998, "fiftyDayAverageChangePercent": 0.19463864, "twoHundredDayAverage": 0.046318, "twoHundredDayAverageChange": 0.002882, "twoHundredDayAverageChangePercent": 0.062222034, "marketCap": 7116878, "priceToBook": 0.22162162, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": 0.0069999993, "regularMarketTime": 1683892037, "regularMarketDayHigh": 0.0492, "regularMarketDayRange": "0.0437 - 0.0492", "regularMarketDayLow": 0.0437, "regularMarketVolume": 16434, "regularMarketPreviousClose": 0.0422, "bid": 0.0431, "ask": 0.0832, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.0437, "averageDailyVolume3Month": 493, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.024499997, "fiftyTwoWeekLowChangePercent": 0.9919027, "fiftyTwoWeekRange": "0.0247 - 0.1024", "fiftyTwoWeekHighChange": -0.0532, "firstTradeDateMilliseconds": 1531893600000, "symbol": "4CX.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Adelgatan 21", "city": "Malm\u00f6", "zip": "221 22", "country": "Sweden", "phone": "46 7 08 88 21 72", "website": "https://www.cyxone.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cyxone AB (publ), a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis, multiple sclerosis, and treatments for virally induced acute respiratory disorders. Its development portfolio comprises Rabeximod in a clinical Phase II program for rheumatoid arthritis and Covid-19 infections; and T20K, a Phase 1 candidate drug for the treatment of multiple sclerosis. The company was incorporated in 2015 and is based in Malm\u00f6, Sweden.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Mr. Carl-Magnus  Hogerkorp", "age": 52, "title": "CEO & Director", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ola  Skanung", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Erika  Samuelsson", "age": 46, "title": "Chief Devel. Officer", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}